Operating Expenses Veränderung Datum
AbbVie USD 11.11B 540M 2023-12
Acadia Pharmaceuticals USD 196.1M 73.38M 2023-12
Acorda Therapeutics USD 33.31M 427K 2023-06
ALKERMES USD 337.09M 41.11M 2023-09
Amgen USD 6.93B 2.11B 2023-12
Bayer EUR 13.94B 1.94B 2023-09
Biogen USD 2.03B 344.1M 2023-12
BioMarin Pharmaceutical USD 631.99M 76.32M 2023-12
Bluebird Bio USD 97.12M 4.93M 2023-09
Bristol-Myers Squibb USD 9.62B 984M 2023-12
Eli Lilly USD 6.97B 2.08B 2023-12
Esperion Therapeutics USD 61.5M 1.34M 2023-09
Gilead Sciences USD 5.5B 1.08B 2023-12
Incyte USD 826.07M 121.75M 2023-12
Intra Cellular Therapies USD 166.2M 10.31M 2023-12
Marinus Pharmaceuticals USD 38.98M 1.46M 2023-09
Merck USD 16.56B 6.35B 2023-12
Moderna USD 2.8B 1.04B 2023-12
Neurocrine Biosciences USD 357.6M 21.5M 2023-09
Pfizer USD 20.8B 4.62B 2023-12
PTC Therapeutics USD 438.79M 124.05M 2023-12
Regeneron Pharmaceuticals USD 2.46B 209.7M 2023-12
Sarepta Therapeutics USD 380.16M 87.4M 2023-09
Teva Pharmaceutical Industries USD 3.5B 1.03B 2023-09
Ultragenyx Pharmaceutical USD 249.44M 6.29M 2023-12
United Therapeutics USD 354.6M 72.2M 2023-12
Vertex Pharmaceuticals USD 1.45B 21.4M 2023-09



Biogen Betriebsaufwand - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Mar 2024.